Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy

NCT01521598 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT01521598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01521598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy
Lead sponsor
SK Life Science, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2013
Enrollment
128 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

painful diabetic neuropathy